Key Challenges and Scopes of Biomaterials Commercialization: Therapeutic Delivery

Bio-nanomaterials have been widely tested and applied in medicine as cargo/adjuvants for chemotherapeutics and prophylactic chemotherapeutics or vaccines. Extensive list of bio-nanomaterials mediated by various microorganisms, plants, cell lines, and biological molecules have been tested against pathogens and diseases of public and animal health significance. However, due to some hurdles, the efficient industrialization of these models is still lacking. The unification and optimization of laboratory-scale models can lead to more harmonized clinical applications. This chapter highlights the areas of promising medical applications as well as the way forward to adequate commercialization of bio-nanotechnology.